Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes

Brain Research

Volumn 1017, Issue 1-2, 2004, Pages 130-136

  Howlett, David R ^a   Richardson, Jill C ^a   Austin, Angela ^a   Parsons, Andrew A ^a   Bate, Simon T ^a   Davies, D Ceri ^b   Gonzalez, M Isabel ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

A neuropathology; Alzheimer's cognitive function; Cognitive impairment; Degenerative disease:; Disorders of the nervous system; Electron microscopy; Quantitative immunohistochemistry

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL DEGENERATION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTRON MICROSCOPE; FEMALE; FUNCTION TEST; GENE MUTATION; GLIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NEURITE; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PLAQUE FORMING CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; SPECIES COMPARISON; TRANSGENIC MOUSE; WILD TYPE; AGE; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; COMPARATIVE STUDY; DISEASE MODEL; ELECTRON MICROSCOPY; GENETICS; METABOLISM; METHODOLOGY; MUTATION; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; SENILE PLAQUE; SEXUAL DEVELOPMENT; ULTRASTRUCTURE;

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MEMBRANE PROTEIN; PRESENILIN 1;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MUTATION; NEUROPSYCHOLOGICAL TESTS; PRESENILIN-1; SENILE PLAQUES; SEX CHARACTERISTICS;

EID: 3142668938     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.05.029     Document Type: Article

References (40)

1. Aggleton J.P., Shaw C. Amnesia and recognition memory: a re-analysis of psychometric data. Neuropsychologia. 34:1996;51-62
2. Allsop D., Christie G., Gray C., Holmes S., Markwell R., Owen D., Smith L., Wadsworth H., Ward R.V., Hartmann T., Lichtenthaler S.F., Evin G., Fuller S., Masters C.L., Beyreuther K., Roberts G.W. Iqbal K., Winblad B., Nishimura T., M.Takeda H.M. Alzheimer's Disease: Biology, Diagnostics and Therapeutics. 1997;717-727 Wiley, New York
3. Arendash G.W., King D.L., Gordon M.N., Morgan D., Hatcher J.M., Hope C.E., Diamond D.M. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891:2001;42-53
4. Bondolfi L., Calhoun M., Ermini F., Kuhn H.G., Wiederhold K.H., Walker L., Staufenbiel M., Jucker M. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J. Neurosci. 22:2002;515-522
5. Borchelt D.R., Ratovitski T., Vanlare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin-1 and amyloid precursor proteins. Neuron. 19:1997;939-945
6. Callahan M.J., Lipinski W.J., Bian F., Durham R.A., Pack A., Walker L.C. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am. J. Pathol. 158:2001;1173-1177
7. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., Justice A., McConlogue L., Games D., Freedman S.B., Morris R.G. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature. 408:2000;975-979
8. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., George-Hyslop P., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276:2001;21562-21570
9. Dodart J.C., Meziane H., Mathis C., Bales K.R., Paul S.M., Ungerer A. Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav. Neurosci. 113:1999;982-990
10. Ennaceur A., Neave N., Aggleton J.P. Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat. Behav. Brain Res. 80:1996;9-25
11. Flood D.G., Reaume A.G., Dorfman K.S., Lin Y.G., Lang D.M., Trusko S.P., Savage M.J., Annaert W.G., De Strooper B., Siman R., Scott R.W. FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction. Neurobiol. Aging. 23:2002;335-348
12. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego, CA
13. Gaffan D. Dissociated effects of perirhinal cortex ablation, fornix transection and amygdalectomy: evidence for multiple memory systems in the primate temporal lobe. Exp. Brain Res. 99:1994;411-422
14. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoyazavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing v717f beta-amyloid precursor protein. Nature. 373:1995;523-527
15. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.M., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4:1998;97-100
16. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav. Genet. 29:1999;177-185
17. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102
18. Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., Hyman B.T. A-beta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein v717f (PDAPP) transgenic mouse. J. Neurosci. 17:1997;7053-7059
19. Jeffries S., Burns A. Clinical assessment of Alzheimer's disease in Neurobiology of Alzheimer's disease. Dawbarn D., Allen S.J. Neurobiology of Alzheimer's Disease. 2001;280-293 Oxford Univ. Press, Oxford
20. Kelly P.H., Bondolfi L., Hunziker D., Schlecht H.P., Carver K., Maguire E., Abramowski D., Wiederhold K.H., Sturchler-Pierrat C., Jucker M., Bergmann R., Staufenbiel M., Sommer B. Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiol. Aging. 24:2003;365-378
21. King D.L., Arendash G.W. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol. Behav. 75:2002;627-642
22. Kotilinek L.A., Bacskai B., Westerman M., Kawarabayashi T., Younkin L., Hyman B.T., Younkin S., Ashe K.H. Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J. Neurosci. 22:2002;6331-6335
23. Kurt M.A., Davies D.C., Kidd M., Duff K., Rolph S.C., Jennings K.H., Howlett D.R. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp. Neurol. 171:2001;59-71
24. Larson J., Lynch G., Games D., Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840:1999;23-35
25. McGowan E., Sanders S., Iwatsubo T., Takeuchi A., Saido T., Zehr C., Yu X., Uljon S., Wang R., Mann D., Dickson D., Duff K. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol. Dis. 6:1999;231-244
26. Meunier M., Bachevalier J., Mishkin M., Murray E.A. Effects on visual recognition of combined and separate ablations of the entorhinal and perirhinal cortex in rhesus monkeys. J. Neurosci. 13:1993;5418-5432
27. Moechars D., Destrooper B., Vanleuven F. Molecular and behavioral characterization of transgenic mice expressing mutant app in the brain. Behav. Genet. 25:1995;280
28. Moechars D., Lorent K., De Strooper B., Dewachter I., van Leuven F. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15:1996;1265-1274
29. Moechars D., Lorent K., van Leuven F. Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis. Neuroscience. 91:1999;819-830
30. Mumby D.G. Perspectives on object-recognition memory following hippocampal damage: lessons from studies in rats. Behav. Brain Res. 127:2001;159-181
31. Mumby D.G., Pinel J.P. Rhinal cortex lesions and object recognition in rats. Behav. Neurosci. 108:1994;1-8
32. Richardson J.C., Kendal C.E., Anderson R., Priest F., Gower E., Soden P., Gray R., Topps S., Howlett D.R., Lavender D., Clarke N.J., Barnes J.C., Haworth R., Stewart M.G., Rupniak H.T.R. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease. Neuroscience. 122:2003;213-228
33. Rockenstein E., Mallory M., Mante M., Sisk A., Masliaha E. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of A beta(1-42). J. Neurosci. Res. 66:2001;573-582
34. Sato T. A modified method for lead staining of thin sections. Jpn. J. Electron Microsc. 17:1968;158-159
35. Selkoe D.J., Podlisny M.B. Deciphering the genetic basis of Alzheimer's disease. Annu. Rev. Genomics Hum. Genet. 3:2002;67-99
36. Smith D.J., Stevens M.E., Sudanagunta S.P., Bronson R.T., Makhinson M., Watabe A.M., O'Dell T.J., Fung J., Weier H.-U.G., Cheng J.-F., Rubin E.M. Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat. Genet. 16:1997;28-36
37. Sturchler Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U. S. A. 94:1997;13287-13292
38. Vidal M., Morris R., Grosveld F., Spanopoulou E. Tissue-specific control elements of the Thy-1 gene. EMBO J. 9:1990;833-840
39. Wang J., Tanila H., Puolivali J., Kadish I., van Groen T. Gender differences in the amount and deposition of amyloid beta in APPswe and PS1 double transgenic mice. Neurobiol. Dis. 14:2003;318-327
40. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., Carlson G.A., Younkin S.G., Ashe K.H. The relationship between A beta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22:2002;1858-1867